PET and SPECT imaging in veterinary medicine

Seminars in Nuclear Medicine

Volumn 44, Issue 1, 2014, Pages 47-56

  Leblanc, Amy K ^a   Peremans, Kathelijne ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 2 BETA CARBOXYMETHOXY 3 BETA [4 IODOPHENYL]TROPANE I 123; 3' FLUOROTHYMIDINE F 18; BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; CYSTEINE ETHYL ESTER TC 99M; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; FLUOROTHIAHEPTADECANOIC ACID F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; MEDRONATE TECHNETIUM TC 99M; N [3 FLUOROPROPYL] 2 BETA CARBOMETHOXY 3BETA [4 IODOPHENYL]NORTROPANE I 123; PREDNISONE; R91150; R91150 I 123; RADIOPHARMACEUTICAL AGENT; SODIUM FLUORIDE F 18; TRACER; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; BIRD; BRAIN PERFUSION; CAT; CLINICAL RESEARCH; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOG; ECHOGRAPHY; EUROPE; FALSE NEGATIVE RESULT; GAMMA CAMERA; HUMAN; INSULINOMA; LYMPHOMA; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; RADIODIAGNOSIS; RADIOLOGIST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TECHNOLOGY; THYROID CARCINOMA; TREATMENT RESPONSE; UNITED STATES; VETERINARIAN; VETERINARY MEDICINE; WHOLE BODY PET;

ANIMALS; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VETERINARY MEDICINE;

EID: 84889675406     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2013.08.004     Document Type: Article

References (86)

1. S.M. Larson, P.L. Weiden, and Z. Grunbaum Positron imaging feasibility studies. II. Characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: Concise communication J Nucl Med 22 1981 869 874
2. R.L. Page, P.K. Garg, and S. Garg PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment J Nucl Med 35 1994 1506 1513
3. C.L. Matwichuk, G.B. Daniel, and L.A. Bowman Fluorine-18 fluorodeoxyglucose accumulation in blastomyces dermatitidis-associated inflammation in a Dog Clin Positron Imaging 2 1999 217 221
4. C.L. Bassett, G.B. Daniel, and A.M. Legendre Characterization of uptake of 2-deoxy-2-[18F]fluoro-d-glucose by fungal-associated inflammation: The standardized uptake value is greater for lesions of blastomycosis than for lymphoma in dogs with naturally occurring disease Mol Imaging Biol 4 2002 201 207
5. T. Beyer, D.W. Townsend, and T. Brun A combined PET/CT scanner for clinical oncology J Nucl Med 41 2000 1369 1379
6. 18F- fluorodeoxyglucose positron emission tomography Vet Radiol Ultrasound 53 2012 591 597
7. J.W. Keyes SUV: Standard uptake value or silly useless value? J Nucl Med 36 1995 1836 1839
8. R.L. Wahl, H. Jacene, and Y. Kasamon From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors J Nucl Med 50 2009 122S 150S
9. 18FDG) with positron emission tomography in the normal dog Vet Radiol Ultrasound 49 2008 182 188
10. 18F]fluoro-d-glucose in adult cats Vet Radiol Ultrasound 50 2009 435 440
11. 18F-FDG uptake with PET-CT in dogs Vet Radiol Ultrasound 51 2010 670 673
12. 18F-FDG assessed by PET/CT Vet Radiol Ultrasound 51 2010 130 135 [Erratum in: Veterinary Radiology & Ultrasound. 2010 Nov-Dec;51(6):699]
13. 18F)FDG-PET in normal hispaniolan Amazon parrots (Amazona ventralis) Vet Radiol Ultrasound 52 2011 340 344
14. 18F] fluoro-d-glucose in the coelom of healthy bald eagles (Haliaeetus leucocephalus) Am J Vet Res 74 2013 426 432
15. A.K. LeBlanc, B.W. Jakoby, and D.W. Townsend PET imaging in canine lymphoma and cutaneous mast cell tumor Vet Radiol Ultrasound 50 2009 215 223
16. E.A. Ballegeer, L.J. Forrest, and R. Jeraj PET/CT following intensity-modulated radiation therapy for primary lung tumor in a dog Vet Radiol Ultrasound 47 2006 228 233
17. E.A. Ballegeer, C. Hollinger, and C.M. Kunst Imaging diagnosis- multicentric lymphoma of granular lymphocytes imaged with FDG PET/CT in a dog Vet Radiol Ultrasound 54 2013 75 80
18. A.E. Hansen, F. McEvoy, and S.A. Engelholm FDG PET/CT imaging in canine cancer patients Vet Radiol Ultrasound 52 2011 201 206
19. 18F) FDG-PET/CT to assess response to toceranib phosphate therapy in canine cancer Vet Radiol Ultrasound 53 2012 348 357
20. B.T. Kang, S.G. Kim, and C.Y. Lim Correlation between fluorodeoxyglucose positron emission tomography and magnetic resonance imaging findings of non-suppurative meningoencephalitis in 5 dogs Can Vet J 51 2010 986 992
21. 18F]fluorothymidine Semin Nucl Med 37 2007 429 439
22. 18F]FLT-PET imaging does not always "light up" proliferating tumor cells Clin Cancer Res 18 2012 1303 1312
23. 18F-FLT for differentiation between tumor and inflammation in rats Nucl Med Biol 36 2009 681 686
24. A. Van Waarde, and P.H. Elsinga Proliferation markers for the differential diagnosis of tumor and inflammation Curr Pharm Des 14 2008 3326 3339
25. 18F]fluorothymidine PET/CT for evaluating response to cytotoxic chemotherapy in dogs with non-Hodgkin's lymphoma Vet Radiol Ultrasound 50 2009 660 668
26. 18FLT) in healthy adult cats Vet Radiol Ultrasound 2013 ([Epub ahead of print])
27. 18F]FLT PET imaging Leuk Res 35 2011 310 316
28. S.M. McGuire, Y. Menda, and L.L. Ponto A methodology for incorporating functional bone marrow sparing in IMRT planning for pelvic radiation therapy Radiother Oncol 99 2011 49 54
29. A. Agool, R.H. Slart, and P.M. Kluin F-18 FLT PET: A noninvasive diagnostic tool for visualization of the bone marrow compartment in patients with aplastic anemia: A pilot study Clin Nucl Med 36 2011 286 289
30. 18F- fluoride PET/CT in benign and malignant bone diseases Bone 50 2012 128 139
31. A. Valdés-Martínez, S.L. Kraft, and C.M. Brundage Assessment of blood pool, soft tissue, and skeletal uptake of sodium fluoride F-18 with positron emission tomography-computed tomography in four clinically normal dogs Am J Vet Res 73 2012 1589 1595
32. M. Bruehlmeier, B. Kaser-Hotz, and R. Achermann Measurement of tumor hypoxia in spontaneous canine sarcomas Vet Radiol Ultrasound 46 2005 348 354
33. 64Cu-ATSM PET in dogs with spontaneously occurring tumors Physiol Med Biol 53 2008 217 232
34. 64Cu-ATSM autoradiography in spontaneous canine tumors: Comparison with pimonidazole hypoxia immunohistochemistry Radiat Oncol 7 2012 89
35. 18FDG PET/CT and dynamic contrast enhanced perfusion CT Radiother Oncol 102 2012 424 428
36. 18F] Fluoro-6-thia-heptadecanoic acid (FTHA): Evaluation in mouse of a new probe of myocardial utilization of long chain fatty acids J Nucl Med 32 1991 1888 1896
37. A. Ebert, H. Herzog, and G. Stöcklin Kinetics of 14(R,S)-fluorine-18-fluoro-6-thia-heptadecanoic acid in normal human hearts at rest, during exercise and after dipyridamole injection J Nucl Med 35 1994 51 56
38. 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: Effects of hypoxia and composition of exogenous fatty acids J Nucl Med 47 2006 173 181
39. A. Hibbert, T. Gruffydd-Jones, and E.L. Barrett Feline thyroid carcinoma: Diagnosis and response to high-dose radioactive iodine treatment J Feline Med Surg 11 2009 116 124
40. K.L. Wucherer, and V. Wilke Thyroid cancer in dogs: An update based on 638 cases (1995-2005) J Am Anim Hosp Assoc 46 2010 249 254
41. D. Gunn-Moore, and K.W. Simpson Insulinoma in cats J. Rand, Clinical Endocrinology of Companion Animals (ed) 2013 John Wiley & Sons Ames Iowa
42. R.S. Hess Insulinoma in dogs J. Rand, Clinical Endocrinology of Companion Animals (ed) 2013 John Wiley & Sons Ames, IA
43. J.H. Robben, H.A. Visser-Wisselaar, and G.R. Rutteman In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas J Nucl Med 38 1997 1036 1042
44. J.H. Robben, Y.W. Pollak, and J. Kirpensteijn Comparison of ultrasonography, computed tomography, and single-photon emission computed tomography for the detection and localization of canine insulinoma J Vet Intern Med 19 2005 15 22
45. C.E. Reusch Pheochromocytoma in dogs J. Rand, Clinical Endocrinology of Companion Animals (ed) 2013 John Wiley & Sons Ames, IA
46. 123Iodine metaiodobenzylguanidine scintigraphy for the diagnosis of a phaeochromocytoma in a dog Vet Radiol ultrasound 34 1993 52 55
47. 123I]iodobenzylguanidine: Concise communication J Nucl Med 25 1984 436 440
48. P.D. Mozley, C.K. Kim, and J. Mohsin The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma J Nucl Med 35 1994 1138 1144
49. M. van Kroonenburgh, R. Mostard, and S. Voo Metaiodobenzylguanidine scintigraphy in pulmonary and cardiac disease Curr Opin Pulm Med 16 2010 511 515
50. T. Waelbers, K. Peremans, and S. Vermeire The effect of medetomidine on the regional cerebral blood flow in dogs measured using Technetium-99m-Ethyl Cysteinate Dimer SPECT Res Vet Sci 91 2011 138 143
51. 123I-R91150 measured with SPECT in the canine brain Vet Anaesth Analg 40 2012 13 14 ([Abstract presented at the spring meeting of the Association of Veterinary Anaesthetists, Davos, Switzerland, March 22-23, 2012.])
52. T. Waelbers, K. Peremans, and S. Vermeire Regional distribution of technetium-99m-ECD in the canine brain: Optimal injection-acquisition interval in adult beagles J Vet Behav 7 2012 261 267
53. M. Ichise, H. Golan, and J.R. Ballinger Regional differences in technetium-99m-ECD clearance on brain SPECT in healthy subjects J Nucl Med 38 1997 1253 1260
54. S. Asenbaum, T. Brucke, and W. Pirker Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: A comparison J Nucl Med 39 1998 613 618
55. 99mTc-hexamethylpropylene amine oxime single photon emission computed tomography. Vet Radiol Ultrasound (in press)
56. S. Vermeire, K. Audenaert, and A. Dobbeleir Regional cerebral blood flow changes in dogs with anxiety disorders, measured with SPECT Brain Imaging Behav 3 2009 342 349
57. S. Vermeire, K. Audenaert, and M.R. De Neuro-imaging the serotonin 2A receptor as a valid biomarker for canine behavioural disorders Res Vet Sci 91 2011 465 472
58. E.K. Miller, and J.D. Cohen An integrative theory of prefrontal cortex function Annu Rev Neurosci 24 2001 167 202
59. J.M. Kent, and S.L. Rauch Neurocircuitry of anxiety disorders Curr Psychiatry Rep 5 2003 266 273
60. S.J. Kim, I.K. Lyoo, and Y.S. Lee Decreased cerebral blood flow of thalamus in PTSD patients as a strategy to reduce re-experience symptoms Acta Psychiatr Scand 116 2007 145 153
61. K. Engel, B. Bandelow, and O. Gruber Neuroimaging in anxiety disorders J Neural Transm 116 2009 703 716
62. K. Wahlund, and M. Kristiansson Aggression, psychopathy and brain imaging - Review and future recommendations Int J Law Psychiatry 32 2009 266 271
63. H. Anckarsater, S. Piechnik, and M. Tullberg Persistent regional frontotemporal hypoactivity in violent offenders at follow-up Psychiatry Res 156 2007 87 90
64. V. Martle, K. Peremans, and K. Audenaert Regional brain perfusion in epileptic dogs evaluated by technetium-99m-ethyl cysteinate dimer SPECT Vet Radiol Ultrasound 50 2009 655 659
65. M.J. Yune, J.D. Lee, and Y.H. Ryu Ipsilateral thalamic hypoperfusion on interictal SPECT in temporal lobe epilepsy J Nucl Med 39 1998 281 285
66. T.R. Henry, J.C. Mazziotta, and J. Engel Jr. Quantifying interictal metabolic activity in human temporal lobe epilepsy J Cereb Blood Flow Metab 10 1990 748 757
67. V. Martle, K. Peremans, and H.L. Van High-resolution micro-SPECT to evaluate the regional brain perfusion in the adult Beagle dog Res Vet Sci 94 2013 701 706
68. T. Waelbers, K. Peremans, and S. Vermeire Effects of medetomidine and ketamine on the regional cerebral blood flow in cats: A SPECT study Vet J 192 2012 81 88
69. T. Waelbers, K. Peremans, and S. Vermeire Regional brain perfusion in 12 cats measured with technetium-99m-ethyl cysteinate dimer pinhole single photon emission computed tomography (SPECT) J Feline Med Surg 15 2013 105 110
70. K. Peremans, K. Audenaert, and F. Coopman Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with Tc-99m ECD and I-123 5-I-5-R91150 Eur J Nucl Med 30 2003 1538 1546
71. K. Peremans, K. Audenaert, and Y. Hoybergs The effect of citalopram hydrobromide on 5-HT2A receptors in the impulsive-aggressive dog, as measured with 123I-5-I-R91150 SPECT Eur J Nucl Med Mol Imaging 32 2005 708 716
72. K. Peremans, I. Goethals, and V.F. De Serotonin transporter and dopamine transporter imaging in the canine brain Nucl Med Biol 33 2006 907 913
73. 123I-5-I-R91150 and single-photon emission tomography before and after low-dose pipamperone administration in the canine brain Nucl Med Commun 29 2008 724 729
74. 123I-5I-R91150 and SPECT J Nucl Med 50 2009 284 289
75. S. Vermeire, K. Audenaert, and A. Dobbeleir A Cavalier King Charles dog with shadow chasing: Clinical recovery and normalization of the dopamine transporter binding after clomipramine treatment J Vet Behav 5 2010 345 349
76. S. Vermeire, K. Audenaert, and M.R. De Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorder Psychiatry Res 201 2012 78 87
77. P. Soloff, J. Price, and C. Meltzer 5HT(2A) receptor binding is increased in borderline personality disorder Biol Psychiatry 62 2007 580 587
78. K. Audenaert, K. Van Laere, and F. Dumont Decreased frontal serotonin 5-HT2a receptor binding index in deliberate self harm patients Eur J Nucl Med 28 2001 175 182
79. F. Biver, D. Wikler, and F. Lotstra Serotonin 5-HT2 receptor imaging in major depression: Focal changes in orbito-insular cortex Br J Psychiatry 171 1997 444 448
80. 123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers Neuropsychopharmacology 32 2007 1661 1668
81. D. Perani, V. Garibotto, and A. Gorini In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder Neuroimage 42 2008 306 314
82. 123I]{beta}-CIT SPECT Am J Psychiatry 161 2004 2201 2206
83. S. Hesse, U. Muller, and T. Lincke Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder Psychiatry Res 140 2005 63 72
84. Waelbers T, Polis I, Vermeire S, et al. Ketamine decreases the brain 5-HT2A receptor binding index in cats measured with micro-single photon emission computed tomography. J Nucl Med (in press).
85. K. Peremans, S. Vermeire, and A. Dobbeleir Recognition of anatomical predilection sites in canine elbow pathology on bone scans using micro-single photon emission tomography Vet J 188 2011 64 72
86. K. Peremans, L. Duchateau, and S. Vermeire The use of the HiSPECT bone scan in canine flexor enthesopathy and coronoid pathology Res Vet Sci 94 2013 628 633